Efficacy and Safety of Rituximab in Treating Adult Patients with Minimal Change Disease and Focal Segmental Glomerulosclerosis: A Prospective Study Compared with Glucocorticoids

Zhao YX, Li X, Cheng X, Pan Y, Liu L

Drug Design, Development and Therapy 2025, 19:10571-10587

Published Date: 27 November 2025